Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +6.56% | 0.00% | +5.41% |
Jun. 07 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.41% | 78.11M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.96% | 22.78B | |
-11.09% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CGTX Stock
- News Cognition Therapeutics, Inc.
- B. Riley Cuts Cognition Therapeutics' PT to $5 From $15, Notes Near-Term Dilution, Expanding R&D Efforts to Execute on Phase II/III Programs; Keeps Buy Rating